Document is current
Any future updates will be listed below
-
Authors
Dubreuil, Maureen https://orcid.org/0000-0002-6253-1515
Magrey, Marina https://orcid.org/0000-0002-6520-5619
Haeffs, Kathrin https://orcid.org/0009-0000-3134-7478
Ivanov, Evgueni
Gandrup Horan, Julie https://orcid.org/0000-0002-4109-4889
-
Funding
Funding for this research was provided by:
UCB
- License Information
-
More Information
Article History
Received: 15 May 2025
Accepted: 5 August 2025
First Online: 29 August 2025
Declarations
:
: Maureen Dubreuil: Received educational grant from Pfizer paid to institution; received consulting fees from Amgen and UCB; Marina Magrey: Received consultancy fees from AbbVie, BMS, Eli Lilly, Novartis, Pfizer, and UCB; received research grants from AbbVie, BMS, and UCB; Kathrin Haeffs, Evgueni Ivanov, Julie Gandrup Horan: Employees and shareholders of UCB.
: This article is based on previously conducted studies and does not contain any new studies, performed by any of the authors, with human participants or animals. As the study analyzed a retrospective anonymized dataset, no ethical review and no informed consent of patients was needed. However, the study protocol was reviewed by a scientific steering committee and the data owner. The work on the dataset conformed to all social security data protection requirements.
